Nifty slips below 24,000 as crude spike, tariffs rattle Dalal Street
Indian equities extended losses on Wednesday as Sensex fell over 800 points and Nifty 50 slipped below 24,000 in intraday trade, tracking a spike in Brent crude above 92 dollars and renewed US tariff risks for Indian pharma exporters. Broader indices underperformed and volatility rose, although some auto and consumer names managed small gains.
Market overview
| Index | 22 Jul 2026 Close | Move & % Change | Comments |
|---|---|---|---|
| Sensex | approx. 76,700, 77,400 intraday range | about -800 pts (-1%) from previous close | Hit low near 76,641, dragged by banks, IT, pharma. |
| Nifty 50 | approx. 23,960, 24,000 intraday range | about -200 pts (-1%) from previous close | Broke 24,000 support, low near 23,961. |
| Nifty Midcap 100 | not stated | down about 1% | Underperformed large caps, broad-based selling. |
| Nifty Smallcap 100 | not stated | down about 1% | Risk-off mood hit smaller stocks harder. |
| Nifty Midcap 150 | not stated | down 0.68% | Pressure persisted across midcap universe. |
| Nifty Smallcap 250 | not stated | down about 1% | Weak breadth, more declines than advances. |
| India VIX | 13.14 | +4% approx. | Volatility jumped as geopolitical and policy risks rose. |
- Intraday, Sensex touched 76,641.19, down over 800 points or about 1%.
- Nifty 50 hit an intraday low of 23,961.40, down over 200 points.
- Another print showed Nifty at 23,973.70, off 214 points (0.88%) at day’s low.
- BSE market capitalisation fell by about ₹4.25 lakh crore to ₹480 lakh crore.
- NSE breadth turned weak, with 2,165 declines, 802 advances, and 82 unchanged.
Key movers
Top gainers
| Stock | Sector | Notable Factor |
|---|---|---|
| Titan | Consumer discretionary | Traded marginally higher, one of few Sensex gainers. |
| Maruti Suzuki | Auto | Managed small gains despite broad market weakness. |
| Eternal | Not specified | In the green with marginal gains, bucked the selloff. |
- Select auto and consumer names outperformed in an otherwise weak tape.
Top losers
| Stock | Sector | Notable Factor |
|---|---|---|
| IndiGo (InterGlobe Aviation) | Aviation | Slumped over 3%, led Sensex losers. |
| State Bank of India | Banking | Dropped nearly 2%, weighed on financial indices. |
| Infosys | IT services | Fell over 1%, part of tech-led drag. |
| Axis Bank | Banking | Declined over 1%, added to financials’ pressure. |
| ICICI Bank | Banking | Down over 1%, contributed to Nifty Bank weakness. |
| UltraTech Cement | Cement | Slipped over 1%, cyclical sentiment hit. |
| Reliance Industries | Energy & telecom | Dropped over 1%, heavy-weight impact on indices. |
| HDFC Bank | Banking | Fell over 1%, extended recent underperformance. |
| Kotak Mahindra Bank | Banking | Lost over 1%, part of private bank decline. |
| Sun Pharma | Pharma | Down over 1%, hurt by US tariff overhang. |
| Tech Mahindra | IT services | Declined over 1%, in line with IT index fall. |
- Pharma names such as Lupin, Piramal Pharma, Glenmark, Cipla dropped up to 4%.
- All 19 Nifty Pharma constituents traded in the red in early trade.
Sectoral action
| Sector/Index | Direction (approx.) | Key Drivers |
|---|---|---|
| Nifty Pharma | down 1.3, 2% | Hit by Trump’s phased tariffs on US generic imports. |
| Nifty Realty | down about 2% | Risk-off sentiment and rate worries hurt rate-sensitive names. |
| Nifty PSU Bank | down about 2% | Weakness in SBI and peers amid macro concerns. |
| Nifty Financial Services | down over 1% | Selling in large private lenders and NBFCs. |
| Nifty Bank | down over 1% | Pressure from HDFC Bank, ICICI Bank, Axis Bank, SBI. |
| Nifty Private Bank | down over 1% | Private lenders corrected on global yield, rupee worries. |
| Nifty IT | down over 1% | Global tech demand slowdown, trimmed guidance from majors. |
- The Nifty Pharma index stood at 25,747.60, down 1.32% in early trade.
- All Nifty Pharma constituents were negative as investors repriced US revenue risks.
- Brokerages noted global IT and consulting firms have cut revenue and earnings guidance.
Macro triggers and global cues
| Market/Asset | Movement | Notes |
|---|---|---|
| Brent crude | around +4th straight gain, at $92.67 | Highest since 11 June, on US Iran conflict and supply fears. |
| WTI crude | above $85 | Supported by Middle East tensions and shipping disruptions. |
| USD/INR | rupee at 96.36, -11 paise | Weaker rupee on higher oil and safe-haven dollar demand. |
| US 10-year yield | up to 4.635% | Rose from 4.545% in four sessions, pressuring EM flows. |
| Dollar index | above 101 | Stronger dollar raised risk of FPI outflows. |
- Three Saudi crude tankers reportedly reversed course in the Red Sea after Houthi threats.
- Iran has threatened shipping through the Strait of Hormuz, raising supply disruption risks.
- Goldman Sachs warned Brent could reach $120 if Hormuz disruptions persist.
- US forces extended strikes on Iran, while Tehran warned of wider regional escalation.
- US President Donald Trump announced phased tariffs on imported generic drugs.
- Generic imports stay at 0% tariff till 1 August 2028, then 100% for one year, 200% thereafter.
- A Reuters poll showed higher perceived odds of a US Fed rate hike later in 2026.
- CME FedWatch implied about 27% probability of a hike, up from earlier.
- The rupee’s weakness reflected concerns on India’s import bill and inflation outlook.
- “Elevated energy prices have increased concerns over India’s import bill and inflation outlook” said Jateen Trivedi, VP Research Analyst, Commodity and Currency, LKP Securities.
Valuation and flows backdrop
- Nifty 50 one-year forward PE is near 20 times, below its 10-year average of about 21 times.
- Expected FY27 Nifty EPS growth is pegged at 15, 16%, supporting long-term earnings visibility.
- Bharti AXA Life CIO Rahul Bhuskute sees low probability of an index washout in 2026.
- He said that Indian corporate earnings remain resilient despite the US Iran conflict.
- “Nifty’s core growth drivers remain attractive” said Bhuskute, citing moderated valuations.
- He flagged global liquidity tightening from higher US yields as the primary risk to equities.
- Bhuskute expects potential FPI flow reversal as domestic earnings momentum improves.
- He favours diversified exposure across large, mid and small caps given sectoral growth recovery.
Technical and market statistics
| Statistic | Value/Change | Context |
|---|---|---|
| Nifty 50 key level | intraday low 23,961.40 | Broke psychological 24,000 support, signalling near-term weakness. |
| Sensex key level | intraday low 76,641.19 | Extended losing streak, pressured by financials and IT. |
| India VIX | 13.14, up over 4% | Jump in implied volatility as geopolitical, policy risks rose. |
- Nifty’s breach of 24,000 came amid broad-based selling across sectors.
- Broader indices’ near 1% fall indicated risk aversion beyond index heavyweights.
- Rising VIX suggested traders are paying more for downside protection.
Frequently Asked Questions
Why did Nifty fall below 24,000 today?
Nifty slipped below 24,000 as crude rose above 92 dollars on escalating US Iran tensions, the dollar and US bond yields climbed, and Trump’s generic drug tariff plan triggered selling in pharma and financial stocks.
Which sectors were hit the most in today’s market fall?
Pharma, realty, PSU banks, financial services, banks and IT led the decline, with Nifty Pharma down over 1% as all 19 constituents fell on worries about future US tariffs on generic drug exports.
What is the medium term outlook for Nifty despite today’s selloff?
Bharti AXA Life’s CIO Rahul Bhuskute sees Nifty’s core growth drivers as intact, with FY27 EPS expected to grow 15, 16% and the one year forward PE near 20 times, slightly below its 10 year average, suggesting some valuation support.
Disclaimer
The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.
